Elaine J. Goldenberg

This summary pertains to Elaine J. Goldenberg, an attorney appearing as Of Counsel at Quinn Emanuel Urquhart & Sullivan, as indicated by the provided case data. Publicly available information regarding patent litigation attorneys named Elaine J. Goldenberg primarily details a different highly accomplished appellate lawyer with a distinct firm and practice focus. The following summary is therefore limited to the available data concerning the Elaine J. Goldenberg associated with patent litigation at Quinn Emanuel.

Based on tracked appearances, Elaine J. Goldenberg's patent litigation experience includes work on the defense side. Her sole tracked case, 10x Genomics, Inc. et al. v. Vizgen, Inc., indicates involvement in the biotechnology or life sciences sector, specifically regarding patents related to spatial genomics technology and gene-mapping tools.

Currently, Elaine J. Goldenberg is Of Counsel at Quinn Emanuel Urquhart & Sullivan. Her involvement in 10x Genomics, Inc. et al. v. Vizgen, Inc., a patent infringement dispute, saw her representing defendant Vizgen, Inc. in the District of Delaware. The case, which concerned Harvard's patents dedicated to gene-mapping technologies, reached a global settlement after three days of trial in February 2025.

There is no reliably sourced information indicating Elaine J. Goldenberg's regular appearance in PTAB or IPR proceedings in connection with patent litigation. Similarly, specific details regarding bar admissions or education for the Elaine J. Goldenberg associated with Quinn Emanuel's patent litigation practice are not readily available through public searches, distinct from those pertaining to other attorneys sharing the same name.